Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Glutathione S-transferase P–c-Jun N-terminal kinase (GSTP1–JNK) complex is a regulatory protein-protein interaction that serves as a key switch in the cellular stress response and apoptotic pathways (Adler et al., 1999, EMBO J). In its basal state, GSTP1 binds to the C-terminal region of JNK, inhibiting its phosphorylation and preventing the activation of downstream pro-apoptotic signaling (Laborde, 2010, Anticancer Agents Med Chem). This sequestration is particularly relevant in oncology, as many tumors overexpress GSTP1 to suppress JNK-mediated apoptosis, thereby contributing to chemoresistance and tumor survival (Tew, 2007, Free Radic Biol Med). Therapeutic targeting of this complex focuses on small molecules that disrupt the GSTP1–JNK interaction or inhibit GSTP1's enzymatic activity, such as Ezatiostat (TLK199) and NBD-18 (Zhang et al., 2014, Methods Enzymol). By releasing JNK from the complex, these drugs restore the cell's ability to undergo programmed cell death in response to stress or chemotherapy. Consequently, the GSTP1–JNK complex represents a significant target for sensitizing resistant tumors and treating hematological malignancies like myelodysplastic syndrome (Ruscoe et al., 2001, J Pharmacol Exp Ther).
Disruption of the protein-protein interaction to release and activate JNK, promoting apoptosis in cancer cells.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase P–c-Jun N-terminal kinase complex (GSTP1–JNK complex).